Insulin Resistance Atherosclerosis Study (IRAS)

NCT00005135 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-08-08

No results posted yet for this study

Summary

To conduct a multicenter study of the relationship between insulin resistance and cardiovascular disease (CVD) and its risk factors in a tri-ethnic (African-American, Hispanic, and non-Hispanic white) population aged 40 to 69 years at baseline. Also, to identify the genetic determinants of insulin resistance and visceral adiposity.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Richard Bergman · University of Southern California

  • Donald Bowden · Wake Forest University

  • Michael Bryer-Ash · University of California, Los Angeles

  • Steven Haffner · University of Texas

  • Jill Norris · University of Colorado, Denver

  • Marian Rewers · University of Colorado Health Science Center

  • Mohammed Saad · University of Southern California

  • Joseph Selby · Kaiser Foundation Research Institute

  • Lynne Wagenknecht · Wake Forest University

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-09-30
Primary Completion
2008-12-31
Completion
2008-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005135 on ClinicalTrials.gov